Literature DB >> 6325898

Characterization of a non-functional form of C1q found in patients with a genetically linked deficiency of C1q activity.

K B Reid, R A Thompson.   

Abstract

A genetically defective form of C1q was purified from the sera of patients suffering from an immune complex related disease and who were homozygous for the defect. The defective C1q was haemolytically inactive and did not bind to immune aggregates or IgG-Sepharose. It showed the following similarities to the normal C1q molecule: a high glycine content and the presence of hydroxyproline and hydroxylysine; subunits with apparent mol. wts of 70,000 and 56,000, when examined by SDS-polyacrylamide gel electrophoresis under non-reducing conditions; preferential incorporation of 125I-label into only one of the types of chain present in the molecule, in a manner similar to that found for the C-chain of normal C1q. However, the defective molecule had an apparent mol. wt of approximately 155,000 in non-dissociating conditions, which is approximately one-third of the mol. wt of the normal molecule. Also, the material in the defective molecule preparation which corresponded, on the basis of mol. wt, to the disulphide-linked A-chain-B-chain dimer of normal C1q differed from that found in the normal molecule in that it did not appear to be sensitive to reducing agents. Collagenase and pepsin treatment of specific immunoprecipitates containing the radiolabelled defective molecule indicated that it is, like the normal molecule, composed of collagenous and non-collagenous domains.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6325898     DOI: 10.1016/0161-5890(83)90121-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Molecular cloning and characterization of the complementary DNA and gene coding for the B-chain of subcomponent C1q of the human complement system.

Authors:  K B Reid
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

Review 2.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

3.  A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual.

Authors:  R A McAdam; D Goundis; K B Reid
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 4.  C1q as an autocrine and paracrine regulator of cellular functions.

Authors:  Berhane Ghebrehiwet; Kinga H Hosszu; Ellinor I B Peerschke
Journal:  Mol Immunol       Date:  2016-11-30       Impact factor: 4.407

5.  In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.

Authors:  R Veerhuis; L A van Es; M R Daha
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

6.  Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE).

Authors:  M Kirschfink; F Petry; K Khirwadkar; R Wigand; J P Kaltwasser; M Loos
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  The C1q family of proteins: insights into the emerging non-traditional functions.

Authors:  Berhane Ghebrehiwet; Kinga K Hosszu; Alisa Valentino; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2012-04-05       Impact factor: 7.561

Review 8.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.